![Arnold & Porter](/cdn-cgi/image/width=256/https://www.legal500.com/profiles/wp-content/uploads/sites/13/2022/05/50060.jpg)
Arnold & Porter
About
Arnold & Porter Kaye Scholer LLP is a leading international law firm with 14 offices across the US, Europe, and Asia. The firm is a trusted adviser to a wide range of leading multinational and domestic organisations and we are globally renowned for our regulatory, transactional, and dispute resolution experience.
The firm: Arnold & Porter’s London office has a well-established record for handling ground-breaking cases since opening in 1997. The office is home to the firm’s European regulatory and corporate and finance practices and includes specialists in life sciences, medical devices, intellectual property, telecoms, technology, product liability, data privacy, commercial litigation and arbitration, competition, white-collar crime, and employment. The firm is a trusted adviser to a wide range of clients including multinational and domestic organisations, financial institutions, sovereign States, and early-stage companies and individuals.
Types of work undertaken
Commercial dispute resolution: strong experience in handling large-scale international commercial litigation including shareholder, joint venture, partnership disputes, banking litigation, complex civil fraud cases, competition High Court related cases, corporate reputation, and regulatory investigations.
Competition: advises on both EU and UK competition law issues being dual-qualified in the UK and Germany. Represents clients from a broad range of industries before the UK Competition and Markets Authority in complex competition matters, including merger control and foreign direct investment, allegations of abuses of dominant position, and behavioural competition advice. Has a particularly strong track record in the pharma and life sciences space as well as in consumer goods and media.
Corporate: advises on domestic and cross-border M&A, joint ventures, strategic alliances, public takeovers, shareholder disputes, venture capital, and mid-market private equity transactions where the firm have considerable experience.
Data protection: counsels on domestic and international data protection matters, including global data protection compliance projects for multinational companies and responding to data breaches. Represents a broad range of clients including financial, media and technology organisations, and medical device and pharmaceutical companies.
Employment: the employment team advises on all areas of employment, including the HR aspects of data protection. The team’s offering extends to business immigration, assisting clients to bring key staff from overseas to the UK. The team has a particularly strong reputation in international employment, handling the employment aspects of mergers and outsourcings, which frequently extend across multiple countries. The team has a roster of household name clients, especially among life sciences, technology and retail businesses.
Finance: advises leading investment banks, private equity funds and other financial institutions in relation to general banking, syndicated and leveraged finance and structured finance transactions such as structured credits and derivatives. Leading debt capital markets capability in relation to representing sovereign bond issuers including debut and diaspora bond offerings.
Intellectual property and technology: assess and counsel on challenging IP and tech issues, effectively manage disputes, coordinate high-stakes litigation and provide strategic IP advice as well as leading transactional support, with specialist expertise in licensing and collaborations. Our capabilities span the full spectrum of IP rights, including patents, trademarks, copyright, database rights, design rights and trade secrets.
International arbitration: handles informal and institutional dispute settlement proceedings including serving as advocates, advisors, and arbitrators in disputes between sovereign governments and private investors, assisting in disputes arising out of concession agreements and other state contracts or under the terms of bilateral investment treaties and other international agreements.
Investment management: advises on the structuring, formation, promotion, regulation and operation of closed and open-ended investment funds, as well as on managed accounts and structures for these. Regulatory advice includes coverage of AIFMD, MiFID, FCA rules and other applicable UK and EU regulations and equivalent SEC provisions.
Life sciences: one of the largest pharmaceutical and medical device regulatory practices in Europe, dealing with all aspects of pre- and post-marketing obligations and interactions with, and challenges to, decisions of regulatory authorities including on issues arising from emerging technologies such as gene and cell therapy products, digital health, and pharmacogenomics.
Product liability: a large team of specialist lawyers, some also qualified in scientific disciplines such as medicine, that is experienced in advising on product safety regulations and conducting the defence of unitary and group product liability proceedings relating to medicines, medical devices, foods, pesticides and other chemical and non-chemical products.
White-collar defence: advises corporates on how to handle investigations in relation to potential economic crime offences with an increasing focus on matters relating to FCPA, anti-bribery and money laundering compliance, together with economic crime defence, self-reporting and negotiations with law enforcement agencies, both in the UK and US.
Other offices: Amsterdam, Brussels, Chicago, Denver, Houston, Los Angeles, Newark, New York, San Francisco, Seoul, Shanghai, Silicon Valley, Washington DC